Retatrutide vs Tirzepatide
Retatrutide vs Tirzepatide: the material compared side by side — what each compound acts on, how it is supplied, its documented purity and the batch certificate of analysis (CoA). Every compound is supplied strictly for research and analytical purposes.
Retatrutide vs Tirzepatide

- Research area
- Weight-loss and metabolism research
- Receptor target
- Triple agonist: GLP-1, GIP and glucagon receptors
- Presentation
- Pre-filled multi-dose pen · 2/4/8 mg setting
- Strength
- 32 mg
- HPLC purity
- 98.75%
- Certificate (CoA)
- Published: see the batch report
- Studied alongside
- Tirzepatide

- Research area
- Weight-loss and metabolism research
- Receptor target
- Dual agonist: GLP-1 and GIP receptors
- Presentation
- Pre-filled multi-dose pen
- Strength
- 60 mg
- HPLC purity
- 99.27%
- Certificate (CoA)
- Published: see the batch report
- Studied alongside
- Retatrutide
Supplied strictly for research and analytical purposes. Not for human consumption and not medical advice. The data above describe the material as delivered; purity comes from the published certificate of analysis (CoA) of the current batch.
Retatrutide vs Tirzepatide: the comparison
Retatrutide vs Tirzepatide: the material compared side by side — what each compound acts on, how it is supplied, its documented purity and the batch certificate of analysis (CoA). Every compound is supplied strictly for research and analytical purposes. The table above shows, for each compound, the receptor target and mechanism, the format, the documented HPLC purity of the current batch and a link to the published certificate of analysis (CoA). Prices are shown in euros and are updated from the current catalogue.
These data describe the material as delivered. Body Pharm publishes no human dosing protocols and no efficacy claims: every compound is strictly for research and analytical use, and not for human consumption.
Body Pharm against other suppliers
Data-based comparisons between the Body Pharm catalogue and other research peptide suppliers in Spain and Europe: format, amount of active compound, price per milligram, certificate of analysis and delivery, side by side. Research use only.